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ABSTRACT - Purpose: Monocarboxylate transporters (MCT) are proton-coupled integral membrane proteins
that control the influx and efflux of endogenous monocarboxylates such as lactate, acetate and pyruvate. They
also transport and mediate the clearance of drugs such as valproate and gamma-hydroxybutyrate. CD147 functions
as ancillary protein that chaperones MCT1 and MCT4 to the cell membrane. There is limited data on the
maturation of MCT and CD147 expression in tissues related to drug distribution and clearance. The objective of
the present study was to quantify hepatic MCT1, MCT4, and CD147 mRNA, whole cell and membrane protein
expression from birth to sexual maturity. Methods: Liver tissues were collected from male and female Sprague
Dawley rats at postnatal days (PND) 1, 3, 5, 7, 10, 14, 18, 21, 28, 35, and 42 (n = 3 - 5). Hepatic mRNA, total and
membrane protein expression of MCT1, MCT4, and CD147 was evaluated via qPCR and western blot. Results:
MCT1 mRNA and protein demonstrated nonlinear maturation patterns. MCT1 and CD147 membrane protein
exhibited low expression at birth, with expression increasing three-fold by PND14, followed by a decline in
expression at sexual maturity. MCT4 mRNA had highest expression at PND 1, with decreasing expression towards
sexual maturity. In contrast, MCT4 membrane protein exhibited minimal expression from birth through weaning
before a 10-fold surge at PND35, whereupon there was a sharp decline in expression at PND42. There was a
significant positive correlation between MCT1 and CD147 whole cell and membrane expression, while MCT4
membrane expression demonstrated a weak negative correlation with CD147. Conclusion: Our study elucidates
the transcriptional and translational maturation patterns of MCT1, MCT4 and CD147 expression, with isoformdependent differences in the liver. Changes in transporter expression during development may greatly influence
drug distribution and clearance in pediatric populations.
__________________________________________________________________________________________
INTRODUCTION
nateglinide, salicylate, atorvastatin, and γhydroxybutyrate (GHB) (5-7). There are two
monocarboxylate transporter families, SLC16A and
SLC5A;
however,
only
proton-dependent
monocarboxylate transporters (MCTs) encoded by
SLC16A are expressed in the liver. There are 14
members in the MCT family with MCT1 through 4
(SLC16A1, SLC16A7, SLC16A8 and SLC16A3)
involved in proton-coupled transport with
overlapping substrate specificity (5, 8). MCT1 and 4,
the primary MCTs expressed in the liver, are sorted
and inserted into the basolateral plasma membrane
of hepatocytes through their association with the
ancillary protein CD147 (9).
_________________________________________

Maturation of drug elimination pathways contributes
to the wide range of inter-individual variability in
drug disposition observed in pediatric populations.
Clinical pharmacokinetic studies have identified
post-natal age as a significant factor influencing
clearance, with hepatic and renal elimination
representing the primary mechanisms of drug
clearance (1, 2). Developmental change in hepatic
drug clearance are governed by maturation of
metabolism and drug transport pathways. While
maturation of drug metabolizing enzymes (3), and
major hepatic drug transporters (4) have been
extensively studied in multiple species, there is
limited data evaluating the maturation of
monocarboxylate transporters in the liver.
Monocarboxylate transporters are involved in
the active transport of essential nutrients and
pharmaceutical agents, including lactate, pyruvate,
butyrate and ketone bodies, nicotinate, valproic acid,
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MCTs function as bidirectional transporters with
directional flux of MCT substrates governed by the
pH gradient (10), with rate of transport also
dependent on MCT and CD147 expression and colocalization (11). Changes in the regulation or
trafficking of MCTs leading to differences in
membrane expression can alter the hepatic transport
of their substrates, leading to alterations in
intracellular drug concentrations. Differences in
hepatic transport may impact overall drug exposure,
which can lead to toxic or sub-therapeutic drug levels
during development (2). It is vital to understand the
maturation of these transporters to optimize
therapeutic regimens for their substrates.
There is limited information in the literature on
the maturation of monocarboxylate transporters in
tissues related to drug disposition. MCT1 has
transient embryonic expression in the dorsal and
lateral anlage of rat cerebral cortex (12), whereas in
the gluteus medius muscle in horse, MCT1 increases
and MCT4 is stably expressed with age (13),
suggesting MCTs are regulated in a tissue-specific
manner. MCT expression differs based on species,
with minimal expression of MCT1 in hamster liver,
whereas MCT1 is the predominant isoform
expressed in mouse, rat, and human livers (12).
Proteomic studies of human hepatic MCT1 show
nonlinear, age-dependent levels of expression (13).
These studies indicate that MCT maturation should
be evaluated in individual tissues to identify tissuespecific maturation patterns of each isoform and the
potential impact on drug pharmacokinetics. The
objective of the present study is to quantify agedependent hepatic mRNA, total and membrane
protein expression of MCTs and their ancillary
protein CD147 in male and female rats, to evaluate
their developmental regulation with respect to
transcription, translation and membrane trafficking.

was removed from each litter at individual post-natal
time points. Pups were weaned at 21 days of age.
Rats were group housed (except pregnant females)
and kept under controlled lighting (12h light/dark
cycle) and temperature (20 ± 2oC) conditions with
food and water provided ad libitum. Liver samples
were collected (N = 3 - 5 per gender per age group)
from post-natal day (PND) 1 through 42 following
exsanguination under isoflurane anesthesia, and snap
frozen in liquid nitrogen with storage at -80oC. Body
and liver weights are detailed in Figure 1.
Sex Determination: Sex was assigned for pups less
than PND21 by ano-genital distance at the time of
tissue collection and was confirmed by PCR. Liver
(25 mg) was utilized to isolate genomic DNA using
a PureLink Genomic DNA Mini Kit (Invitrogen)
following the manufacturer’s instructions. DNA
concentration and purity was evaluated using a
Nanodrop (Thermo Scientific). The presence of
SRY, a Y specific sequence, and β-actin (PCR
control) were evaluated by end-point PCR following
a previously published method with minor
modifications (14). Briefly, 2 μl of genomic DNA
was combined with AmpliTaq Gold (ThermoFisher)
and corresponding buffer, 0.2 mM dNTPs, 0.2 μM
forward and reverse primers (Table 1) with a final
reaction volume of 25 μl. PCR reactions were run
separately for each gene. Samples were run through
a thermal cycle using a T100 Thermal Cycler
(BioRad) as follows: 1 minute at 95oC, 1 minute at
52oC, and 1 minute at 72oC with the cycle repeated
35 times. PCR products were separated on a 1.4%
agarose gel containing SYBR Safe (Invitrogen) in
1X TBE buffer, run at 100 V for 45 minutes and
visualized using ChemiDoc Touch imaging system
(BioRad).
qPCR: Liver (10 mg) was homogenized and
RNA was isolated using a PureLink RNA Mini kit
(Invitrogen) according to the manufacturer’s
instructions with a DNase treatment step. RNA
concentration and purity was assessed using a
Nanodrop (Thermofisher). RNA stability was
verified by RNA Flash Gel (Lonza) to visualize 18S
and 28S rRNA bands. 1000 ng of total RNA was
added to each 20 μL cDNA synthesis reaction, which
was reverse transcribed using iScript Reverse
Transcription
Supermix
(BioRad).
Primer
sequences, annealing temperatures, product sizes
and assay validation were previously described (15).

METHODS
Animals and Tissue Collection: All animal
experiments were approved by the Institutional
Animal Care and Use Committees of University at
Buffalo (SUNY) and University of the Pacific. Male
and female Sprague-Dawley rats (> 21 days of age),
pregnant females (E14 on arrival) and lactating
females with litters (post-natal day seven on arrival)
were obtained from Envigo (USA). For pups less
than 21 days of age, one male and one female pup
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Table 1: Primer sequences and amplicon size for sex determination assay from (14).
Primer

Primer Sequence

B-Actin Forward

AGCCATGTACGTAGCCATCC

B-Actin Reverse

TGTGGTGGGAAGCTGTAGC

SRY Forward

TACAGCCTGAGGACATATTA

SRY Reverse

CGACTTTAACCCTTCGATGA

Amplicon Size (bp)
220
317

were performed with iTaq Universal SYBR Green
Supermix as described previously (15) on a CFX96
Connect (BioRad) with a standard curve run on every
plate. The external control Alien RNA (Agilent) was
utilized for data normalization. All biological
samples were run in triplicate. The purity of all qPCR
products was determined by melting curve. Data was
quantified by 2−ΔΔCT method (16) or in arbitrary units
based on the standard curve.
Western Blot Analysis: Whole cell extracts were
generated from 25 mg of rat liver tissue and 500 ul
of ice-cold radioimmunoprecipitation assay (RIPA)
lysis buffer containing UltraCruz Protease Inhibitor
Cocktail (Santa Cruz Biotechnology). Samples were
briefly homogenized then spun at 13,500 rpm in a
4oC microcentrifuge to collect protein supernatants.
Soluble cytosolic and total membrane fractions were
isolated from 25 mg liver samples using a
Calbiochem ProteoExtract Native Membrane
Protein Extraction Kit (EMD-Millipore) following
the
manufacturer’s
instructions.
Protein
concentrations were calculated using the Pierce BCA
Protein Assay kit (Thermo Fisher Scientific). MCT1,
MCT4 and CD147 protein expression was quantified
using western blot analysis of whole cell extract or
membrane fraction. Samples (10 μg whole cell
extract or 5 μg membrane fraction) were mixed with
2x Laemmli sample buffer (BioRad) and heated at
37°C for 30 minutes, then loaded onto 10% TGX
Fastcast acrylamide gels (Biorad) and separated via
SDS-PAGE at 200V for approximately 45 minutes.
Following transfer onto nitrocellulose membranes at
100V for 25 minutes, membranes were blocked in
5% nonfat milk in phosphate-buffered saline with
Tween 20 (PBST) for 1 hour at ambient temperature,
then incubated for 16 hours at 4oC under gentle
rocking with anti-MCT1 (1:1350, EMD Millipore),
anti-MCT4 (1:1000, Santa Cruz Biotechnology),
anti-CD147 (1:5000, Santa Cruz Biotechnology), or
anti-Na+/K+ ATPase (1:1000, Santa Cruz
Biotechnology). All antibodies were formulated in

Figure 1: Body [A] and liver weights (normalized to body
weight) [B] for male and female Sprague-Dawley rats
from birth to sexual maturity. Data is presented as mean ±
SD (N = 4 – 5 rats per age and sex). *P < 0.05.

Serial dilutions of plasmids (covering 5 to 6 orders
of magnitude) containing the gene-specific amplicon
were used as standards to confirm qPCR efficiency
and to quantify relative gene expression.
Quantitative analyses of MCT1, MCT4, and CD147
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1% nonfat milk/PBST. After washing three times for
10 min in PBST, blots were incubated with goat antirabbit IgG horseradish peroxidase-conjugated
(1:5000 Santa Cruz Biotechnology) or donkey antigoat IgG horseradish peroxidase-conjugated
secondary antibodies (1:10000 EMD Millipore) for
1 hour at ambient temperature. Following a final
3×10 min PBST wash, immunoreactive bands were
visualized using Clarity Western ECL substrate
(Biorad) and band densities determined using
ChemiDoc Touch Imaging System (Biorad).

MCT1 Expression
Males and females had similar nonlinear
transcriptional MCT1 profiles during development
(Figure 3a and 3b). Expression generally increased
with age, with peak mRNA levels at PND10 in the
males and PND 14 in females, before decreasing
incrementally towards PND42. In males (Figure 3c),
MCT1 whole cell protein expression was lowest at
PND1, before increasing gradually with the highest
expression observed at PND14, before reverting to
expression levels consistent with neonatal animals at
adolescence (PND42). A similar trend was observed
in the females (Figure 3d), although expression was
higher at PND1 and lower at PND42 as compared to
the males. Similar patterns were observed for MCT1
membrane expression (Figure 3e and 3f), with
reduced expression at PND1 and PND42, and
significantly higher expression at PND14 and
PND18 in the males and females, with the males also
having significantly increased expression at PND10.

Data Analysis: Data is presented as mean ± standard
deviation. Data was analyzed in GraphPad Prism 6
software using one-way analysis of variance
(ANOVA), followed by Tukey’s HSD post hoc test.
Differences of p < 0.05 in post-hoc comparison were
considered to be significant. Pearson correlation
analysis in GraphPad Prism 6 was used to evaluate
the relationships between whole cell and membrane
protein expression of MCT1, MCT4 and CD147.

MCT4 Expression
Males and females had similar linear transcriptional
MCT4 profiles during development (Figure 4a and
4b), with the highest levels in neonatal rats at PND1,
3, 5, and 7, before decreasing incrementally with age
towards PND42 (adolescents). This differed from the
observed patterns for MCT1 suggesting transporterspecific
developmental
regulation.
MCT4
expression was undetectable in whole cell protein
samples over the age range evaluated for both sexes.
In males and females, membrane protein was
minimally expressed at PND1, before increasing
incrementally to peak at PND35, before decreasing
drastically at PND42 (Figure 4c and 4d).

RESULTS
Sex Determination
Sex was assigned at tissue collection by ano-genital
distance for all pups less than PND21 with a target
of four males and four females per age group. Based
on PCR analysis of the SRY sequence, sex
assignments were accurate for all pups at PND5 and
later (data not shown). At PND1, the final PCR sex
assignments yielded three male and five female pups
(Figure 2).

Figure 2: PCR confirmation of sex assignments by ano-genital distance. Genomic DNA was isolated from the liver and SRY
(317 bp) was utilized to confirm the presence of the Y chromosome. B-actin (220 bp) served as a PCR control, and PND 21
animals served as positive controls for sex assignments.
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CD147 Expression
Males and females demonstrated nonlinear
developmental expression patterns for both whole
cell and membrane protein. In males, CD147 whole
protein expression was low at PND1 and increased
to peak levels at PND14 and PND18 (approximately
three times higher expression), before experiencing
a decrease in expression levels towards PND42
(Figure 5a). In females, CD147 expression was low
at PND1, before increasing significantly to its
highest levels at PND14, before decreasing again to
neonatal levels at PND42 (Figure 5b). While males
and females had similar expression levels at PND1,
males had higher whole cell CD147 expression at
PND42 compared to PND1, and to females at
PND42.
Membrane
protein
expression
demonstrated similar expression pattern in both
males and females (Figures 5b and 5c). Males
demonstrated the highest membrane CD147
expression at PND14, while females demonstrated
significantly higher expression at PND10, PND14
and PND18. Consistent with whole cell CD147
expression at PND42, males demonstrated
approximately 2.5 times higher CD147 membrane
expression as compared to females.

MCT4 whole cell and membrane expression could
not be evaluated, as whole cell MCT4 expression
was not detectable. Correlation analysis was
conducted to evaluate the trafficking relationship
between MCT4 and CD147 membrane expression.
In contrast to MCT1, MCT4 membrane expression
demonstrated a weak negative correlation with
membrane CD147 expression; however, this
relationship was not significant in male or females
(Figure 7a and 7b).
DISCUSSION
Monocarboxylate transporters are ubiquitously
expressed in the human body, and studies have
shown MCTs are associated with the absorption and
excretion of monocarboxylate drugs in drug
disposition organs such as the liver, kidneys, and
intestines. The extent of transport capacity is
dependent on MCT membrane protein expression,
with changes in expression altering drug disposition
in cells and tissues. However, there is limited data
regarding the maturation and expression of hepatic
MCTs relative to age, particularly during pediatric
development in both males and females. A technical
obstacle in clinical studies is that hepatic fetal and
infant tissues are often derived postmortem, with
confounding factors such as race, sex, disease, and
polygenic traits, as well as limited sampling size
presenting barriers to controlled pediatric studies
(13, 17). To our knowledge, the present work is the
first analysis of changes in rat hepatic MCT1, MCT4
and CD147 expression at the mRNA, whole cell, and
membrane protein level during early stages of
mammalian growth. Here, we show hepatic MCT1
and CD147 expression changes in a nonlinear
fashion from birth to sexual maturity with a
significant positive correlation between MCT1 and
CD147 membrane expression. The maturation
pattern of MCT4 differed from MCT1, with low
expressions at birth followed by a surge in membrane
expression at PND35. Further, there was a weak
negative correlation between MCT4 and CD147
membrane expression.

Correlation Analysis
In the male ontogeny (Figure 6a), comparisons
between membrane and whole cell MCT1
expression displayed a significant positive
correlation with an r value of 0.545. The female
ontogeny (Figure 6b) had a similar significant
positive correlation with an r value of 0.587.
Correlations on the relationship between MCT1 and
CD147 membrane and whole cell protein expression
were conducted to investigate membrane trafficking.
In males (Figure 6c), there was a significant positive
correlation with an r value of 0.585, while females
(Figure 6d) had a significant positive correlation;
however, the r value (0.342) was lower than that
observed in males. Correlation analysis between
membrane expression of MCT1 and CD147
demonstrated strong significant positive correlations
with r values of 0.8318 and 0.8447 in males and
females (Figure 6e and 6f). Relationships between
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Figure 3: MCT1 mRNA, whole cell and membrane protein expression in males [A, C, E] and females [B, D, F] from birth
to sexual maturity. A, B. Fold-change in MCT1 mRNA expression in rat liver. C, D. Whole cell MCT1 protein expression in
the liver with data normalized to Na+/K+ ATPase expression. A positive control sample (pooled liver whole cell sample from
9 week old male Sprague-Dawley rats) was loaded on each blot. E, F. MCT1 membrane expression in rat liver with data
normalized to Na+/K+ ATPase expression. A positive control sample (pooled liver whole cell sample from 9 week old male
Sprague-Dawley rats) was loaded on each blot. Data is presented as mean ± SD (N = 4 – 5 rats per age and sex). *P < 0.05
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Figure 4: MCT4 mRNA, whole cell and membrane protein expression in males [A, C] and females [B, D] from birth to
sexual maturity. A, B. Fold-change in MCT4 mRNA expression in rat liver relative to PND21 females. C, D. MCT4 membrane
expression in rat liver with data normalized to Na+/K+ ATPase expression. A positive control sample (pooled liver whole cell
sample from 9 week old male Sprague-Dawley rats) was loaded on each blot. Data is presented as mean ± SD (N = 4 – 5 rats
per age and sex). *P < 0.05.

MCT1 is responsible for nutrient transport and
essential for the metabolism of carbohydrates, amino
acids, and fats. Consequently, dysregulation of
MCT1 expression is associated with metabolic
disorders such as obesity and abnormal insulin
secretion (18), as well as altered drug transport and
pharmacokinetics. MCT1 expression is detected as
early as oocyte maturation (19), and knockout of the
transporter leads to embryonic lethality in mouse
animal models, indicating its critical role in early
mammalian development and survival (20).
Comparisons between human fetal (gestational age
range of 16.4-37.9 weeks), infant (postnatal age

range of 0-11.4 weeks, gestational age at birth range
of 27.1-41 weeks), and adult specimen demonstrated
nonlinear maturation of MCT1 membrane protein in
the liver (13), which is consistent with that pattern of
MCT1 maturation observed in the present study.
Maturation of mRNA and whole cell protein
expression of MCT1 was consistent with membrane
protein expression; however, the moderate positive
correlation suggests that MCT1 translation does not
completely account for the transporter’s expression
at the plasma membrane suggesting that other
regulatory factors mediate trafficking of MCT1 to
the cell membrane during development.
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Figure 5: CD147 cell and membrane protein expression in males [A, C] and females [B, D] from birth to sexual maturity. A,
B. Whole cell CD147 protein expression in the liver with data normalized to Na+/K+ ATPase expression. A positive control
sample (pooled liver whole cell sample from 9 week old male Sprague-Dawley rats) was loaded on each blot. C, D. CD147
membrane expression in rat liver with data normalized to Na+/K+ ATPase expression. A positive control sample (pooled liver
whole cell sample from 9 week old male Sprague-Dawley rats) was loaded on each blot. Data is presented as mean ± SD (N
= 4 – 5 rats per age and sex). *P < 0.05.

Developmental mRNA expression of MCT4
diverges from the MCT1 profile, with high mRNA
expression at birth and decreasing levels towards
sexual maturity; however, MCT4 protein data
reverses this trend, with low membrane protein
expression at early ages until a sudden peak at
postnatal age 35. The mechanisms underlying this
discrepancy between MCT4 mRNA and protein
expression are not completely understood. Other
reviews have reported the historically poor
correlation observed between mRNA and ex-vivo
protein in complex biological samples, which
complicates data interpretation for transcriptionaltranslational model predictions (21). Previous
studies have shown that endogenous microRNAs,
miR-29 and miR-124, can degrade MCT1 mRNA or
inhibit its translation, while let-b7 downregulates
CD147 expression (22), similar mechanisms could
explain the discrepancy that we observed between

MCT4 mRNA and protein expression. miR-29 in
particular is highly expressed in β islet cells, which
may explain the diminished amount of MCT1 found
in pancreas compared to other tissues (23), and MCT
regulation by miRNA may explain the observed
tissue differences in expression. While fewer
regulation studies have been performed on MCT4,
the transcription factor HIF-1α has been shown to
upregulate mRNA and protein expression of MCT4
during hypoxia, but not MCT1 (24). However, the
mechanisms regulating MCT4 expression under
normoxic conditions remain to be determined (25).
Further experiments identifying possible miRNA
activity and other post-transcriptional modifications
may explain the dynamic changes in MCT1 and
MCT4 expression based on maturation, with
subsequent upregulation and downregulation events
dependent on MCT isoform, biological sample, and
tissue-type (26).
383
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Figure 6: Pearson correlation analysis in males [A, C, E] and females [B, D, F]. A, B. Correlation analysis between MCT1
whole cell protein and membrane expression. C, D. Correlation analysis between whole cell MCT1 and CD147 expression.
E, F. Correlation analysis between membrane MCT1 and CD147 expression. (N = 42 males; N = 44 females)
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Figure 7: Pearson correlation analysis between membrane MCT4 and CD147 expression in males [A] and females [B]. (N
= 42 males; N = 44 females)

Unlike hepatic transporters and drug
metabolizing enzymes, few studies have looked at
the age-dependent expression of ancillary proteins in
the liver, or their mechanistic roles in drug
transporter maturation. The CD147 glycoprotein
binds to MCT1 and MCT4 and confers basolateral
sorting onto the heterodimer, facilitating the
transporter’s localization to the plasma membrane
where it becomes functionally active (27). Studies
have shown that increased association between
MCT1/4 and CD147 enhances plasma membrane
expression of the transporter (28), whereas
knockdown or silencing of the chaperone in various
cells lines and transgenic animal models causes
decreased MCT1/CD147 association and membrane
co-localization, as well as overall altered tissue
distribution (29). CD147 in the rumen of juvenile
sheep was found to increase linearly based on age
(30). In our experiment, whole cell CD147 protein is
expressed at minimal levels at birth, with increasing
and maximum levels at postnatal ages 14/18 in the
males and postnatal age 14 in females, then
decreasing towards neonatal levels upon sexual
maturity. Membrane levels of CD147 reflect the total
protein trend, with peak expressions at postnatal age
14 in both sexes, and there exists strong, positive
correlation between total and membrane-bound
CD147 protein expression. Comparison of total
protein MCT1 and CD147 yielded a significant
moderate correlation, indicating total translation of
the ancillary protein has minimal impact on whole
protein expression of its transporter partner.
However, we observed a significant strong positive

correlation when comparing the membrane
expression of MCT1 and CD147, signifying a strong
association between the membrane proteins, and
suggesting the ancillary protein is required as a
chaperone for proper MCT1 trafficking to the cell
surface
throughout
normal
mammalian
development, with a nonlinear expressional pattern
dependent on age. In contrast, MCT4 membrane
expression demonstrated a weak negative correlation
with CD147 membrane expression suggesting that
CD147 does not determine MCT4 membrane
expression during development. The present study
did not evaluate MCT4 membrane localization,
which may be altered if it is no longer associated
with CD147.
Previously, our group described the sex hormone
dependent regulation and localization of MCT1 and
MCT4 in the liver, with changes in expression
between male and female rats, as well as in female
rats at various stages in their estrus cycle (15).
Consistent with our previous results, we observed
variability in hepatic MCT1, MCT4, and CD147
expression between the males and females in both
juvenile and sexually mature rats. Males exhibited
increased MCT1 membrane expression at PND10
and 18 compared to the females. Similarly, MCT4
and CD147 membrane protein expression was higher
in males compared to the females in juvenile rats,
implicating a sex-specific, sex-hormone independent
regulatory mechanisms in MCT expression. MCT1,
MCT4 and CD147 membrane expression was higher
in males than females at PND42, at which age rats
will have circulating sex hormones. Increased
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abundance of MCTs and ancillary protein in males
may result in greater hepatic transport capacity for
nutrients and pharmaceutical agents compared to
females, which can lead to increased drug absorption
and reduced hepatobiliary clearance.
Our data is consistent with previous clinical
studies on MCT maturation (13) and suggests several
avenues for future transporter work. The nonlinearity
of hepatic MCT1 expression indicates a clear need to
assess the maturation of drug disposition processes
to account for inter-individual variability in
pharmacokinetics in pediatric populations. Drug
uptake and efflux assays in the liver can also evaluate
the mechanisms between MCT expression and
function during development, as well as between
adolescent male and female populations.
Furthermore, we can explore the effects of age on the
expressional changes of MCTs in other drug
disposition tissues such as the intestines and kidney.
In conclusion, we have demonstrated differential
expression of hepatic MCT1, MCT4, and CD147
during development at the level of mRNA
transcription, protein translation, and membrane
trafficking in a pediatric animal model.
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